• Cytochalasin B: Actin Workflow Guide

  2026-08-23

  Cytochalasin B (NSC 107658) provides a reversible way to perturb actin-dependent migration, division, phagocytosis, and transport while preserving a clear mechanistic control. This guide translates the compound into practical assay workflows, dose-optimization strategies, and safeguards against confusing cytoskeletal target engagement with nonspecific toxicity.

• Sex Differences in Angiotensin II Hypertension

  2026-08-22

  Xue, Pamidimukkala, and Hay used continuous telemetry in conscious mice to show that chronic angiotensin II produces a substantially larger hypertensive response in males than in females. Gonadectomy, phenylephrine baroreflex testing, and ganglionic blockade connected this divergence to sex-dependent hormonal protection, baroreflex resetting, and sympathetic support of blood pressure.

• Methicillin Sodium Salt: MSSA Assay Workflows

  2026-08-21

  Methicillin sodium salt provides a practical PBP-targeted benchmark for MSSA susceptibility testing, gram-positive infection models, and resistance-focused experiments. This guide connects assay design with the endpoint discipline used in modern antibiotic trials while clarifying why methicillin-sensitive and mecA-positive strains must be interpreted differently.

• CCR7–Notch1 Crosstalk Promotes Mammary Cancer Stemness

  2026-08-21

  Boyle et al. showed that CCR7 signaling functionally intersects with Notch1 to maintain stem-like properties in primary MMTV-PyMT mammary cancer cells. By combining genetic CCR7 loss, ligand stimulation, pathway readouts, and Notch inhibition, the study provides a mechanistic rationale for investigating coordinated disruption of both signaling axes.

• Morning Training and Endurance Adaptation in Mice

  2026-08-20

  Hesketh and colleagues show that endurance training during the early active phase produces faster performance gains in female mice than training later in the active phase, despite lower absolute workloads. The study links this training-time effect to skeletal-muscle oxidative and contractile remodeling rather than differences in final liver or muscle glycogen content.

• SB 202190 in Acinar Cell MAPK Assays

  2026-08-20

  SB 202190 is a p38 MAP kinase inhibitor that can separate p38-dependent signaling from cofilin-driven secretion and growth in pancreatic acinar models. This article translates mechanistic findings into assay design, controls, and interpretation strategies for inflammation research, cancer therapeutics research, and apoptosis assays.

• Rapid Recombinant Annexin V Purification: Study Insights

  2026-08-19

  Burger and colleagues developed a short purification strategy for recombinant annexin V that combines mild bacterial-cell opening, reversible calcium-dependent binding to liposomes, and final DEAE ion-exchange chromatography. The resulting protein was reported as highly pure by silver-stained SDS-PAGE and HPLC, providing a practical foundation for structural, electrophysiological, and other biophysical studies.

• Machine Learning Prediction of mRNA Lipid Nanoparticles

  2026-08-18

  This article reviews a study that used LightGBM and molecular modeling to predict lipid nanoparticle formulations for mRNA vaccines from 325 formulation–immunogenicity records. The work linked computational ranking with mouse validation, showing that an MC3-based formulation at an N/P ratio of 6:1 outperformed an SM-102 formulation under the tested conditions.

• Meropenem Trihydrate in Resistance Research

  2026-08-18

  Meropenem trihydrate supports controlled antibacterial exposure, susceptibility testing, and metabolomics workflows that connect phenotype with mechanism. This practical guide shows how to build reproducible assays around the carbapenem antibiotic while avoiding solvent, stability, sampling, and machine-learning pitfalls.

• Cefodizime: Assay Workflows and Research Applications

  2026-08-17

  Cefodizime combines broad antibacterial coverage with a PBP-directed mechanism that is useful for susceptibility testing, time-kill studies, and exposure-aware infection models. This guide translates its MIC profile, formulation constraints, and host-response findings into practical workflows with troubleshooting checkpoints.

• Pertussis Toxin: Applied Workflows for Immune Studies

  2026-08-17

  Use Pertussis toxin as a controlled cAMP-linked perturbation tool for dendritic-cell, T-cell, and vascular assays—not as a universal inflammatory stimulus. This guide connects practical assay design with recent TH17 transcription research while emphasizing dose finding, tissue-specific interpretation, and troubleshooting.

• Glycogen Timing and Exercise Adaptation

  2026-08-16

  Exercise timing can reshape endurance adaptation even when endpoint muscle and liver glycogen levels appear unchanged. This thought-leadership analysis connects circadian exercise biology with practical glycogen measurement, showing how the Glycogen Colorimetric Assay Kit II can help translational researchers distinguish stored carbohydrate content from the broader metabolic context of adaptation.

• Cap 1 Luciferase mRNA as a Translational Control

  2026-08-15

  A thought-leadership guide to using Cap 1 firefly luciferase mRNA as a controlled readout for delivery, translation, gene regulation, and formulation immunogenicity—while translating insights from modern mRNA-LNP research into more rigorous assay design.

• circRHOBTB3–NONO–MAOA Axis in Prostate Cancer

  2026-08-15

  The reference study identifies circRHOBTB3 as a downregulated circular RNA that restrains prostate cancer proliferation and metastasis by retaining NONO in the cytoplasm and reducing MAOA transcription. Its integrated sequencing, RNA–protein interaction, functional, and in vivo experiments define a regulatory axis with potential biomarker value while also implicating SRSF9 and Alu elements in circRHOBTB3 biogenesis.

• SIRT1/2 Inhibitor IV: CNS and Tumor Workflows

  2026-08-14

  SIRT1/2 Inhibitor IV (cambinol) provides a cell-permeable way to interrogate SIRT1- and SIRT2-dependent deacetylation in cancer, metabolic, and oxygen-glucose deprivation/reoxygenation models. This guide connects established p53 and tubulin acetylation assays with an emerging lactate–Ran–STAT3 pathway in astrocytes, while emphasizing controls, dosing logic, and troubleshooting.

451 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page